[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Gastroparesis Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 66 pages | ID: GC2051BD97B0EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Gastroparesis is a disease in which the stomach cannot empty itself of food in a normal fashion. Symptoms include heartburn, nausea, vomiting, and feeling full quickly when eating. Treatments include medications and possibly surgery.

This report contains market size and forecasts of Gastroparesis Treatment in Global, including the following market information:

Global Gastroparesis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Gastroparesis Treatment market was valued at 3923.4 million in 2021 and is projected to reach US$ 4539.4 million by 2028, at a CAGR of 2.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Drug Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Gastroparesis Treatment include Medtronic, Abbott, Bausch Health, Boston Scientific, C.R. Bard, Johnson & Johnson, Cardinal Health, Evoke Pharma and Rhythm Pharmaceuticals. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gastroparesis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Gastroparesis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Gastroparesis Treatment Market Segment Percentages, by Type, 2021 (%)
  • Drug Treatment
  • Surgical Treatment
Global Gastroparesis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Gastroparesis Treatment Market Segment Percentages, by Application, 2021 (%)
  • Hospital
  • Ambulatory Surgical Center
  • Others
Global Gastroparesis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Gastroparesis Treatment Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Gastroparesis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Gastroparesis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Medtronic
  • Abbott
  • Bausch Health
  • Boston Scientific
  • C.R. Bard
  • Johnson & Johnson
  • Cardinal Health
  • Evoke Pharma
  • Rhythm Pharmaceuticals
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Gastroparesis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Gastroparesis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL GASTROPARESIS TREATMENT OVERALL MARKET SIZE

2.1 Global Gastroparesis Treatment Market Size: 2021 VS 2028
2.2 Global Gastroparesis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Gastroparesis Treatment Players in Global Market
3.2 Top Global Gastroparesis Treatment Companies Ranked by Revenue
3.3 Global Gastroparesis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Gastroparesis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Gastroparesis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gastroparesis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Gastroparesis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Gastroparesis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Gastroparesis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Drug Treatment
  4.1.3 Surgical Treatment
4.2 By Type - Global Gastroparesis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Gastroparesis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Gastroparesis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Gastroparesis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Gastroparesis Treatment Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Ambulatory Surgical Center
  5.1.4 Others
5.2 By Application - Global Gastroparesis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Gastroparesis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Gastroparesis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Gastroparesis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Gastroparesis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Gastroparesis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Gastroparesis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Gastroparesis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Gastroparesis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Gastroparesis Treatment Revenue, 2017-2028
  6.3.2 US Gastroparesis Treatment Market Size, 2017-2028
  6.3.3 Canada Gastroparesis Treatment Market Size, 2017-2028
  6.3.4 Mexico Gastroparesis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Gastroparesis Treatment Revenue, 2017-2028
  6.4.2 Germany Gastroparesis Treatment Market Size, 2017-2028
  6.4.3 France Gastroparesis Treatment Market Size, 2017-2028
  6.4.4 U.K. Gastroparesis Treatment Market Size, 2017-2028
  6.4.5 Italy Gastroparesis Treatment Market Size, 2017-2028
  6.4.6 Russia Gastroparesis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Gastroparesis Treatment Market Size, 2017-2028
  6.4.8 Benelux Gastroparesis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Gastroparesis Treatment Revenue, 2017-2028
  6.5.2 China Gastroparesis Treatment Market Size, 2017-2028
  6.5.3 Japan Gastroparesis Treatment Market Size, 2017-2028
  6.5.4 South Korea Gastroparesis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Gastroparesis Treatment Market Size, 2017-2028
  6.5.6 India Gastroparesis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Gastroparesis Treatment Revenue, 2017-2028
  6.6.2 Brazil Gastroparesis Treatment Market Size, 2017-2028
  6.6.3 Argentina Gastroparesis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Gastroparesis Treatment Revenue, 2017-2028
  6.7.2 Turkey Gastroparesis Treatment Market Size, 2017-2028
  6.7.3 Israel Gastroparesis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Gastroparesis Treatment Market Size, 2017-2028
  6.7.5 UAE Gastroparesis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Medtronic
  7.1.1 Medtronic Corporate Summary
  7.1.2 Medtronic Business Overview
  7.1.3 Medtronic Gastroparesis Treatment Major Product Offerings
  7.1.4 Medtronic Gastroparesis Treatment Revenue in Global Market (2017-2022)
  7.1.5 Medtronic Key News
7.2 Abbott
  7.2.1 Abbott Corporate Summary
  7.2.2 Abbott Business Overview
  7.2.3 Abbott Gastroparesis Treatment Major Product Offerings
  7.2.4 Abbott Gastroparesis Treatment Revenue in Global Market (2017-2022)
  7.2.5 Abbott Key News
7.3 Bausch Health
  7.3.1 Bausch Health Corporate Summary
  7.3.2 Bausch Health Business Overview
  7.3.3 Bausch Health Gastroparesis Treatment Major Product Offerings
  7.3.4 Bausch Health Gastroparesis Treatment Revenue in Global Market (2017-2022)
  7.3.5 Bausch Health Key News
7.4 Boston Scientific
  7.4.1 Boston Scientific Corporate Summary
  7.4.2 Boston Scientific Business Overview
  7.4.3 Boston Scientific Gastroparesis Treatment Major Product Offerings
  7.4.4 Boston Scientific Gastroparesis Treatment Revenue in Global Market (2017-2022)
  7.4.5 Boston Scientific Key News
7.5 C.R. Bard
  7.5.1 C.R. Bard Corporate Summary
  7.5.2 C.R. Bard Business Overview
  7.5.3 C.R. Bard Gastroparesis Treatment Major Product Offerings
  7.5.4 C.R. Bard Gastroparesis Treatment Revenue in Global Market (2017-2022)
  7.5.5 C.R. Bard Key News
7.6 Johnson & Johnson
  7.6.1 Johnson & Johnson Corporate Summary
  7.6.2 Johnson & Johnson Business Overview
  7.6.3 Johnson & Johnson Gastroparesis Treatment Major Product Offerings
  7.6.4 Johnson & Johnson Gastroparesis Treatment Revenue in Global Market (2017-2022)
  7.6.5 Johnson & Johnson Key News
7.7 Cardinal Health
  7.7.1 Cardinal Health Corporate Summary
  7.7.2 Cardinal Health Business Overview
  7.7.3 Cardinal Health Gastroparesis Treatment Major Product Offerings
  7.7.4 Cardinal Health Gastroparesis Treatment Revenue in Global Market (2017-2022)
  7.7.5 Cardinal Health Key News
7.8 Evoke Pharma
  7.8.1 Evoke Pharma Corporate Summary
  7.8.2 Evoke Pharma Business Overview
  7.8.3 Evoke Pharma Gastroparesis Treatment Major Product Offerings
  7.8.4 Evoke Pharma Gastroparesis Treatment Revenue in Global Market (2017-2022)
  7.8.5 Evoke Pharma Key News
7.9 Rhythm Pharmaceuticals
  7.9.1 Rhythm Pharmaceuticals Corporate Summary
  7.9.2 Rhythm Pharmaceuticals Business Overview
  7.9.3 Rhythm Pharmaceuticals Gastroparesis Treatment Major Product Offerings
  7.9.4 Rhythm Pharmaceuticals Gastroparesis Treatment Revenue in Global Market (2017-2022)
  7.9.5 Rhythm Pharmaceuticals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. Gastroparesis Treatment Market Opportunities & Trends in Global Market
Table 2. Gastroparesis Treatment Market Drivers in Global Market
Table 3. Gastroparesis Treatment Market Restraints in Global Market
Table 4. Key Players of Gastroparesis Treatment in Global Market
Table 5. Top Gastroparesis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Gastroparesis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Gastroparesis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Gastroparesis Treatment Product Type
Table 9. List of Global Tier 1 Gastroparesis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastroparesis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Gastroparesis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Gastroparesis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Gastroparesis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Gastroparesis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Gastroparesis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Gastroparesis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Gastroparesis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Gastroparesis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Gastroparesis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Gastroparesis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Gastroparesis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Gastroparesis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Gastroparesis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Gastroparesis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Gastroparesis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Gastroparesis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Gastroparesis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Gastroparesis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Gastroparesis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Medtronic Corporate Summary
Table 31. Medtronic Gastroparesis Treatment Product Offerings
Table 32. Medtronic Gastroparesis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Corporate Summary
Table 34. Abbott Gastroparesis Treatment Product Offerings
Table 35. Abbott Gastroparesis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Bausch Health Corporate Summary
Table 37. Bausch Health Gastroparesis Treatment Product Offerings
Table 38. Bausch Health Gastroparesis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Boston Scientific Corporate Summary
Table 40. Boston Scientific Gastroparesis Treatment Product Offerings
Table 41. Boston Scientific Gastroparesis Treatment Revenue (US$, Mn), (2017-2022)
Table 42. C.R. Bard Corporate Summary
Table 43. C.R. Bard Gastroparesis Treatment Product Offerings
Table 44. C.R. Bard Gastroparesis Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Johnson & Johnson Corporate Summary
Table 46. Johnson & Johnson Gastroparesis Treatment Product Offerings
Table 47. Johnson & Johnson Gastroparesis Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Cardinal Health Corporate Summary
Table 49. Cardinal Health Gastroparesis Treatment Product Offerings
Table 50. Cardinal Health Gastroparesis Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Evoke Pharma Corporate Summary
Table 52. Evoke Pharma Gastroparesis Treatment Product Offerings
Table 53. Evoke Pharma Gastroparesis Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Rhythm Pharmaceuticals Corporate Summary
Table 55. Rhythm Pharmaceuticals Gastroparesis Treatment Product Offerings
Table 56. Rhythm Pharmaceuticals Gastroparesis Treatment Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. Gastroparesis Treatment Segment by Type in 2021
Figure 2. Gastroparesis Treatment Segment by Application in 2021
Figure 3. Global Gastroparesis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Gastroparesis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Gastroparesis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gastroparesis Treatment Revenue in 2021
Figure 8. By Type - Global Gastroparesis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Gastroparesis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Gastroparesis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Gastroparesis Treatment Revenue Market Share, 2017-2028
Figure 12. US Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Gastroparesis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Gastroparesis Treatment Revenue Market Share, 2017-2028
Figure 24. China Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Gastroparesis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Gastroparesis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Gastroparesis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Medtronic Gastroparesis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott Gastroparesis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bausch Health Gastroparesis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Boston Scientific Gastroparesis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. C.R. Bard Gastroparesis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Johnson & Johnson Gastroparesis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Cardinal Health Gastroparesis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Evoke Pharma Gastroparesis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Rhythm Pharmaceuticals Gastroparesis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications